Vident Investment Advisory’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,746
| Closed | -$491K | – | 237 |
|
|
2023
Q2 | $491K | Sell |
8,746
-15,207
| -63% | -$853K | 0.02% | 705 |
|
|
2023
Q1 | $1.08M | Buy |
23,953
+2,582
| +12% | +$117K | 0.04% | 502 |
|
|
2022
Q4 | $869K | Buy |
21,371
+6,182
| +41% | +$251K | 0.03% | 524 |
|
|
2022
Q3 | $763K | Buy |
15,189
+2,495
| +20% | +$125K | 0.02% | 665 |
|
|
2022
Q2 | $769K | Sell |
12,694
-4,162
| -25% | -$252K | 0.02% | 713 |
|
|
2022
Q1 | $1.06M | Buy |
16,856
+2,122
| +14% | +$133K | 0.03% | 677 |
|
|
2021
Q4 | $1.12M | Buy |
14,734
+1,880
| +15% | +$143K | 0.03% | 664 |
|
|
2021
Q3 | $1.44M | Sell |
12,854
-1,384
| -10% | -$155K | 0.04% | 561 |
|
|
2021
Q2 | $2.31M | Buy |
14,238
+2,544
| +22% | +$412K | 0.07% | 345 |
|
|
2021
Q1 | $1.43M | Sell |
11,694
-32
| -0.3% | -$3.9K | 0.05% | 508 |
|
|
2020
Q4 | $1.8M | Sell |
11,726
-10,377
| -47% | -$1.59M | 0.07% | 328 |
|
|
2020
Q3 | $1.85M | Sell |
22,103
-819
| -4% | -$68.5K | 0.09% | 243 |
|
|
2020
Q2 | $1.68M | Sell |
22,922
-67
| -0.3% | -$4.92K | 0.09% | 250 |
|
|
2020
Q1 | $975K | Sell |
22,989
-567
| -2% | -$24K | 0.06% | 404 |
|
|
2019
Q4 | $1.44M | Sell |
23,556
-8,365
| -26% | -$510K | 0.09% | 341 |
|
|
2019
Q3 | $1.31M | Sell |
31,921
-912
| -3% | -$37.4K | 0.11% | 135 |
|
|
2019
Q2 | $1.55M | Buy |
+32,833
| New | +$1.55M | 0.12% | 116 |
|